Peking University Third Hospital-Hematology ( Site 2011)

Beijing, Beijing Municipality 100191

1 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Studies at this site

• A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011) — Recruiting now